SCHEMBL27574103

SCHEMBL27574103

CCc1cn(C(O)C(N)CC)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28746318 0.76 GCK (0.34) —
SCHEMBL27550059 0.75 KDM4C (0.41) —
SCHEMBL28748054 0.74 CYP17A1 (0.38) —
SCHEMBL6124221 0.72 CPA1 (0.33) —
SCHEMBL21148770 0.71 CYP2C9 (0.31) —
SCHEMBL27790380 0.65 CPB2 (0.33) —
SCHEMBL21430353 0.65 CYP2C9 (0.31) —
SCHEMBL20012745 0.65 KDM5A (0.31) —
SCHEMBL15267784 0.64 — —
SCHEMBL3014472 0.61 KDM5A (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1324018-C Oligopeptides and compositions containing them as cathepsin S inhibitors AVENTIS PHARMA INC (US) 2007-07-04 — — CN disclosed
Send feedback